Pneumococcal Serotypes Colonise the Nasopharynx in Children at Different Densities.
Prevalence of pneumococcal serotypes in carriage and disease has been described but absolute serotype colonisation densities have not been reported. 515 paediatric nasal swab DNA extracts were subjected to lytA qPCR and molecular serotyping by microarray. Absolute serotype densities were derived from total pneumococcal density (qPCR cycle threshold and standard curve) and relative abundance (microarray) and varied widely. Compared to all serotype densities observed, the strongest evidence of differences was seen for serotypes 21 and 35B (higher) and 3, 38 and non-typeables (lower) (p<0.05) with a similar hierarchy when only a single serotype carriage was assessed. There was no evidence of any overall density differences between children with single or multiple serotypes detected but serotypes with mid-range densities were more prevalent. The hierarchy of distinct pneumococcal serotype carriage densities described here for the first time, may help explain the dynamics of transmission between children.
Hospital Pediátrico Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.|Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal.
Fernanda
F
Rodrigues
School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Leon
L
Danon
School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Begonia
B
Morales-Aza
School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Paulina
P
Sikora
School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Valtyr
V
Thors
Hospital Pediátrico Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Muriel
M
Ferreira
Institute for Infection and Immunity, St. George's, University of London, London, United Kingdom.|BUGS Bioscience, London Bioscience Innovation Centre, London, United Kingdom.
Katherine
K
Gould
Institute for Infection and Immunity, St. George's, University of London, London, United Kingdom.|BUGS Bioscience, London Bioscience Innovation Centre, London, United Kingdom.
Jason
J
Hinds
School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Adam
A
Finn
PLoS Pathog. 2009 Jun;5(6):e1000476
19521509
PLoS Med. 2011 Apr;8(4):e1001017
21483718
J Hyg (Lond). 1928 Jan;27(2):113-59
20474956
Hum Vaccin Immunother. 2016;12 (2):375-82
26367344
Clin Infect Dis. 2000 Jan;30(1):122-40
10619741
PLoS Med. 2015 Nov 17;12(11):e1001903; discussion e1001903
26575033
Science. 2012 Mar 16;335(6074):1376-80
22383809
PeerJ. 2013 Jun 25;1:e97
23825797
Epidemics. 2010 Jun;2(2):80-4
21031138
PLoS One. 2014 Jul 11;9(7):e102045
25013895
BMC Bioinformatics. 2011 Mar 31;12:88
21453458
PLoS Med. 2005 Jan;2(1):e15
15696204
Nat Rev Microbiol. 2008 Apr;6(4):288-301
18340341
J Infect Dis. 2004 Oct 1;190(7):1203-11
15346329